Biggest News Aggregation in the World
📰 Scott Struthers News

Page 2 - Scott Struthers News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scott Struthers. Real-time updates on events, politics, business and more.

Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome

Significant Reductions in Frequency and Intensity of Both Bowel Movements and Flushing Episodes Were Observed Paltusotine was Well-Tolerated with an Overall Pharmacokinetic Profile that was...
Corey Davis Chas Schultz Scott Struthers Natalie Badillo Crinetics Pharmaceuticals Inc Head Of Corporate Communications

Crinetics Pharmaceuticals (NASDAQ:CRNX) Trading Down 3.8% Following Insider Selling

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) traded down 3.8% during trading on Wednesday following insider selling activity. The company traded as low as $32.76 and last traded at $33.04. 482,383 shares were traded during trading, a decline of 37% from the average session volume of 770,039 shares. The stock had previously […]
Zurcher Kantonalbank Zurich Cantonalbank Richard Scott Struthers Robertw Baird Stephenf Betz Crinetics Pharmaceuticals Inc First Republic Investment Management Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Update

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 4,540,000 shares, a growth of 21.4% from the August 15th total of 3,740,000 shares. Based on an average daily volume of 866,100 shares, the short-interest ratio […]
Marc Wilson Robertw Baird Richard Scott Struthers Securities Exchange Commission Crinetics Pharmaceuticals Stock News Ratings For Crinetics Pharmaceuticals Daily

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science